Varenicline as a smoking cessation aid in a Greek population: a subanalysis of an observational study.

ABSTRACT:

Background

Greece has the highest proportion of smokers in the European Union with 42% of Greeks admitting that they smoke, based on a 2009 survey. This post-hoc analysis of a prospective, observational study evaluated the effectiveness and safety profile of the smoking cessation aid varenicline, as well as potential predictors of quit success in a Greek population.

Methods

Participants were prescribed varenicline according to the recommendations of the European Summary of Product Characteristics (1 mg twice daily). The 7-day point prevalence of abstinence at Week 12 was determined based on verbal reporting using a nicotine use inventory. Abstinence was confirmed by carbon monoxide measurements of exhaled air at the last visit of the study. The safety profile of varenicline

SUBMITTER: Gratziou C 

PROVIDER: S-EPMC3395840 | biostudies-literature | 2012 Feb

REPOSITORIES: biostudies-literature